Efficacy and tolerability of latanoprost compared with timolol in the treatment of patients with chronic angle-closure glaucoma

References

• Alward WL. Medical management of glaucoma. N Engl J Med 1998;339:1298-307
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-40
   PubMed Web of Science ®Google Scholar
• Wax MB, Camras CB, Fiscella RG, et al. Emerging perspectives in glaucoma: Optimizing 24-hour control of intraocular pressure. Am J Ophthalmol 2002;133(Suppl):S1-10
   PubMed Web of Science ®Google Scholar
• Parikh RS, Parikh SR, Navin S, et al. Practical approach to medical management of glaucoma. Indian J Ophthalmol 2008;56:223-30
   PubMed Web of Science ®Google Scholar
• Foster PJ, Baasanhu J, Alsbirk PH, et al. Glaucoma in Mongolia. A population-based survey in Hövsgöl province, northern Mongolia. Arch Ophthalmol 1996;114:1235-41
   PubMed Web of Science ®Google Scholar
• Foster PJ, Oen FT, Machin D, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol 2000;118:1105-11
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Iwase A, Araie M, et al. Tajimi Study Group, Japan Glaucoma Society. The Tajimi Study report 2: prevalence of primary angle closure and secondary glaucoma in a Japanese population. Ophthalmology 2005;112:1661-9
   PubMed Web of Science ®Google Scholar
• Foster PJ, Johnson GJ. Glaucoma in China. How big is the problem? Br J Ophthalmol 2001;85:1277-82
   PubMed Web of Science ®Google Scholar
• Vijaya L, George R, Arvind H, et al. Prevalence of angle-closure disease in a rural southern Indian population. Arch Ophthalmol 2006;124:403-9
   PubMed Web of Science ®Google Scholar
• Saw SM, Gazzard G, Friedman DS. Interventions for angle-closure glaucoma: an evidence-based update. Ophthalmology 2003;110:1869-78
   PubMed Web of Science ®Google Scholar
• Robin AL, Pollack IP. Argon laser peripheral iridotomies in the treatment of primary angle closure glaucoma. Long-term follow-up. Arch Ophthalmol 1982;100:919-23
   PubMed Web of Science ®Google Scholar
• Alsagoff Z, Aung T, Ang LP, et al. Long-term clinical course of primary angle-closure glaucoma in an Asian population. Ophthalmology 2000;107:2300-4
   PubMed Web of Science ®Google Scholar
• van der Valk R, Webers CA, Schouten JS, et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005;112:1177-85
   PubMed Web of Science ®Google Scholar
• Cheng JW, Cai JP, Li Y, et al. Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure. J Glaucoma 2009;18:652-7
   PubMed Web of Science ®Google Scholar
• Zhang WY, Po AL, Dua HS, et al. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol 2001;85:983-90
   PubMed Web of Science ®Google Scholar
• Cheng JW, Cai JP, Li Y, et al. A meta-analysis of topical prostaglandin analogs in the treatment of chronic angle-closure glaucoma. J Glaucoma 2009;18:652-7
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org [Last accessed 20 February 2012]
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
   PubMed Web of Science ®Google Scholar
• Aung T, Wong HT, Yip CC, et al. Comparison of the intraocular pressure lowering effect of latanoprost and timolol in patients with chronic angle closure glaucoma a preliminary study. Ophthalmology 2000;107:1178-83
   PubMed Web of Science ®Google Scholar
• Sihota R, Saxena R, Agarwal HC, et al. Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma. Arch Ophthalmol 2004;122:185-9
   PubMed Web of Science ®Google Scholar
• Chew PT, Aung T, Aquino MV, et al. Intraocular pressure–reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma. Ophthalmology 2004;111:427-34
   PubMed Web of Science ®Google Scholar
• Zhao J, Ge J, Sun X, et al. Intraocular pressure-reducing effects of latanoprost versus timolol in chinese patients with chronic angle-closure glaucoma. J Glaucoma 2013;22:591-6
   PubMed Web of Science ®Google Scholar
• Kong XM, Sun XH, Ge L, et al. The clinical study of latanoprost in treating with residual angle-closure glaucoma. Zhongguo Shiyong Yanke Zazhi 2005;23:475-8
   Google Scholar